Format

Send to

Choose Destination
Eur J Med Res. 2010 Feb 26;15(2):66-9.

Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis.

Author information

1
The Laboratory of Shanghai Skin Diseases and STD Hospital, Shanghai, China.

Abstract

OBJECTIVE:

To assess the sensitivity, specificity, and feasibility of a new chemiluminescence immunoassay (CLIA) in the diagnosis of syphilis.

METHODS:

At first, a retrospective study was conducted, using 135 documented cases of syphilis and 30 potentially interfering samples and 80 normal sera. A prospective study was also performed by testing 2, 071 unselected samples for routine screening for syphilis. CLIA was compared with a nontreponemal test (TRUST) and a treponemal test (TPPA).

RESULTS:

There was an agreement of 100% between CLIA and TPPA in the respective study. The percentage of agreement among the 245 sera tested was 100.0%. Compared with TPPA, the specificity of CLIA was 99.9% (1817/1819), the sensitivity of CLIA was 100.0% (244/244) in the prospective study. CLIA showed 99.5% agreement with TPPA by testing 2, 071 unselected samples. And CLIA seemed to be more sensitive than TPPA in detecting the samples of primary syphilis.

CONCLUSIONS:

CLIA is easy to perform and the indicator results are objective and unequivocal. It may be suitable for large-scale screening as a treponemal test substituted for TPPA.

PMID:
20452886
PMCID:
PMC3352047
DOI:
10.1186/2047-783x-15-2-66
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center